<div id="readability-page-1"><p>Norges Bank purchased a new stake in  CorVel Corp. (NASDAQ:CRVL - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 334,869 shares of the business services provider's stock, valued at approximately $34,418,000. Norges Bank owned 0.65% of CorVel at the end of the most recent quarter.</p><p>Several other institutional investors have also recently bought and sold shares of the business. Atria Investments Inc lifted its stake in shares of  CorVel by 1.3% in the second quarter. Atria Investments Inc now owns 14,646 shares of the business services provider's stock valued at $1,505,000 after buying an additional 186 shares in the last quarter.  ProShare Advisors LLC raised its holdings in shares of  CorVel by 3.0% in the 2nd quarter. ProShare Advisors LLC now owns 6,466 shares of the business services provider's stock worth $665,000 after acquiring an additional 189 shares during the last quarter.  Ameritas Investment Partners Inc. lifted its position in  CorVel by 6.8% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,973 shares of the business services provider's stock valued at $306,000 after acquiring an additional 189 shares in the last quarter.  Vanguard Personalized Indexing Management LLC boosted its stake in  CorVel by 4.1% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 5,534 shares of the business services provider's stock valued at $569,000 after purchasing an additional 217 shares during the last quarter.  Finally, Versor Investments LP increased its holdings in  CorVel by 6.5% during the 2nd quarter. Versor Investments LP now owns 4,472 shares of the business services provider's stock worth $460,000 after purchasing an additional 272 shares in the last quarter. Institutional investors and hedge funds own  51.36% of the company's stock. </p><h2>CorVel Stock Down 1.7%</h2><p>Shares of NASDAQ CRVL opened at $69.17 on Monday. CorVel Corp. has a twelve month low of $68.50 and a twelve month high of $128.61. The stock's 50 day moving average price is $73.76 and its 200-day moving average price is $87.57. The company has a market capitalization of $3.54 billion, a PE ratio of 34.07 and a beta of 1.09. </p><p>CorVel (NASDAQ:CRVL - Get Free Report) last issued its quarterly earnings results on Tuesday, November 4th. The business services provider reported $0.54 EPS for the quarter. CorVel had a return on equity of 31.72% and a net margin of 11.28%.The company had revenue of $239.64 million during the quarter. </p><h2>Analyst Upgrades and Downgrades</h2><p>A number of research analysts have recently weighed in on the company. Wall Street Zen lowered CorVel from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Saturday, November 8th. Weiss Ratings  reissued a &#34;hold (c)&#34; rating on shares of CorVel in a research report on Tuesday, October 14th. One investment analyst  has rated the stock with a Hold rating,  Based on data from MarketBeat.com, CorVel  has an average rating of &#34;Hold&#34;.</p><p><b>Check Out Our Latest Research Report on CRVL</b></p><h2>Insiders Place Their Bets</h2><p>In related news, Director R Judd Jessup sold 7,076 shares of the firm's stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $76.94, for a total transaction of $544,427.44. Following the completion of the sale, the director owned 115,045 shares in the company, valued at approximately $8,851,562.30. This trade represents a 5.79% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Mark E. Bertels sold 1,200 shares of the business's stock in a transaction dated Wednesday, November 19th. The shares were sold at an average price of $72.35, for a total transaction of $86,820.00. Following the completion of the transaction, the executive vice president owned 2,594 shares in the company, valued at approximately $187,675.90. The trade was a 31.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 11,733 shares of company stock worth $894,686 over the last quarter. Company insiders own  44.56% of the company's stock. </p><h2>About CorVel</h2> (Free Report)<p>CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.</p><h2>Read More</h2><ul><li>Five stocks we like better than CorVel</li><li>What is a SEC Filing?</li><li>Rubrik’s Massive Rebound: Why the Next Leg Higher Could Be Fast</li><li>What is the MACD Indicator and How to Use it in Your Trading</li><li>Five Below and Dollar Tree Earnings Signal a Shopper Shift</li><li>What is a penny stock? A comprehensive guide</li><li>Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?</li></ul><p><strong>Want to see what other hedge funds are holding CRVL?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CorVel Corp. (NASDAQ:CRVL - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1JWTA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1JWTA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in CorVel Right Now?</h2><p>Before you consider CorVel, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CorVel wasn't on the list.</p><p>While CorVel currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

CRVL

<p>Norges Bank acquired 334,869 shares in CorVel Corp., valued at $34.4 million, during Q2, owning 0.65% of the company. Other institutional investors also increased their stakes. CorVel's stock opened at $69.17, with a market cap of $3.54 billion. Recent analyst ratings suggest a 'Hold' position. Insiders sold shares worth $894,686 last quarter. CorVel provides various health solutions using advanced technology.</p>

334,869 Shares in CorVel Corp. $CRVL Bought by Norges Bank